These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 24989964)

  • 1. 4-Benzothiazole-7-hydroxyindolinyl diaryl ureas are potent P2Y1 antagonists with favorable pharmacokinetics: low clearance and small volume of distribution.
    Qiao JX; Wang TC; Hiebert S; Hu CH; Schumacher WA; Spronk SA; Clark CG; Han Y; Hua J; Price LA; Shen H; Chacko SA; Everlof G; Bostwick JS; Steinbacher TE; Li YX; Huang CS; Seiffert DA; Rehfuss R; Wexler RR; Lam PY
    ChemMedChem; 2014 Oct; 9(10):2327-43. PubMed ID: 24989964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformationally constrained ortho-anilino diaryl ureas: discovery of 1-(2-(1'-neopentylspiro[indoline-3,4'-piperidine]-1-yl)phenyl)-3-(4-(trifluoromethoxy)phenyl)urea, a potent, selective, and bioavailable P2Y1 antagonist.
    Qiao JX; Wang TC; Ruel R; Thibeault C; L'Heureux A; Schumacher WA; Spronk SA; Hiebert S; Bouthillier G; Lloyd J; Pi Z; Schnur DM; Abell LM; Hua J; Price LA; Liu E; Wu Q; Steinbacher TE; Bostwick JS; Chang M; Zheng J; Gao Q; Ma B; McDonnell PA; Huang CS; Rehfuss R; Wexler RR; Lam PY
    J Med Chem; 2013 Nov; 56(22):9275-95. PubMed ID: 24164581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of 1-{2-[4-chloro-1'-(2,2-dimethylpropyl)-7-hydroxy-1,2-dihydrospiro[indole-3,4'-piperidine]-1-yl]phenyl}-3-{5-chloro-[1,3]thiazolo[5,4-b]pyridin-2-yl}urea, a potent, efficacious and orally bioavailable P2Y(1) antagonist as an antiplatelet agent.
    Jeon YT; Yang W; Qiao JX; Li L; Ruel R; Thibeault C; Hiebert S; Wang TC; Wang Y; Liu Y; Clark CG; Wong HS; Zhu J; Wu DR; Sun D; Chen BC; Mathur A; Chacko SA; Malley M; Chen XQ; Shen H; Huang CS; Schumacher WA; Bostwick JS; Stewart AB; Price LA; Hua J; Li D; Levesque PC; Seiffert DA; Rehfuss R; Wexler RR; Lam PY
    Bioorg Med Chem Lett; 2014 Mar; 24(5):1294-8. PubMed ID: 24513044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of 2-(phenoxypyridine)-3-phenylureas as small molecule P2Y1 antagonists.
    Chao H; Turdi H; Herpin TF; Roberge JY; Liu Y; Schnur DM; Poss MA; Rehfuss R; Hua J; Wu Q; Price LA; Abell LM; Schumacher WA; Bostwick JS; Steinbacher TE; Stewart AB; Ogletree ML; Huang CS; Chang M; Cacace AM; Arcuri MJ; Celani D; Wexler RR; Lawrence RM
    J Med Chem; 2013 Feb; 56(4):1704-14. PubMed ID: 23368907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of diarylurea P2Y(1) antagonists with improved aqueous solubility.
    Wang TC; Qiao JX; Clark CG; Jua J; Price LA; Wu Q; Chang M; Zheng J; Huang CS; Everlof G; Schumacher WA; Wong PC; Seiffert DA; Stewart AB; Bostwick JS; Crain EJ; Watson CA; Rehfuss R; Wexler RR; Lam PY
    Bioorg Med Chem Lett; 2013 Jun; 23(11):3239-43. PubMed ID: 23602442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of 4-aryl-7-hydroxyindoline-based P2Y1 antagonists as novel antiplatelet agents.
    Yang W; Wang Y; Lai A; Qiao JX; Wang TC; Hua J; Price LA; Shen H; Chen XQ; Wong P; Crain E; Watson C; Huang CS; Seiffert DA; Rehfuss R; Wexler RR; Lam PY
    J Med Chem; 2014 Jul; 57(14):6150-64. PubMed ID: 24931384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-Aminothiazole based P2Y(1) antagonists as novel antiplatelet agents.
    Pi Z; Sutton J; Lloyd J; Hua J; Price L; Wu Q; Chang M; Zheng J; Rehfuss R; Huang CS; Wexler RR; Lam PY
    Bioorg Med Chem Lett; 2013 Jul; 23(14):4206-9. PubMed ID: 23743287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and biological evaluation of 2-(phenoxyaryl)-3-urea derivatives as novel P2Y
    Peng J; Zhao L; Wang L; Chen H; Qiu Y; Wang J; Yang H; Liu J; Liu H
    Eur J Med Chem; 2018 Oct; 158():302-310. PubMed ID: 30223118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-Amino-1,3,4-thiadiazoles in the 7-hydroxy-N-neopentyl spiropiperidine indolinyl series as potent P2Y1 receptor antagonists.
    Hu CH; Qiao JX; Han Y; Wang TC; Hua J; Price LA; Wu Q; Shen H; Huang CS; Rehfuss R; Wexler RR; Lam PY
    Bioorg Med Chem Lett; 2014 Jun; 24(11):2481-5. PubMed ID: 24767843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent P2Y1 urea antagonists bearing various cyclic amine scaffolds.
    Ruel R; L'Heureux A; Thibeault C; Lapointe P; Martel A; Qiao JX; Hua J; Price LA; Wu Q; Chang M; Zheng J; Huang CS; Wexler RR; Rehfuss R; Lam PY
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6825-8. PubMed ID: 24269480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benzofuran-substituted urea derivatives as novel P2Y(1) receptor antagonists.
    Thalji RK; Aiyar N; Davenport EA; Erhardt JA; Kallal LA; Morrow DM; Senadhi S; Burns-Kurtis CL; Marino JP
    Bioorg Med Chem Lett; 2010 Jul; 20(14):4104-7. PubMed ID: 20542694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, structure-property relationships and pharmacokinetic evaluation of ethyl 6-aminonicotinate sulfonylureas as antagonists of the P2Y₁₂ receptor.
    Bach P; Boström J; Brickmann K; van Giezen JJ; Groneberg RD; Harvey DM; O'Sullivan M; Zetterberg F
    Eur J Med Chem; 2013 Jul; 65():360-75. PubMed ID: 23747805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New azole antagonists with high affinity for the P2Y(1) receptor.
    Ruel R; L'Heureux A; Thibeault C; Daris JP; Martel A; Price LA; Wu Q; Hua J; Wexler RR; Rehfuss R; Lam PY
    Bioorg Med Chem Lett; 2013 Jun; 23(12):3519-22. PubMed ID: 23668989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel series of piperazinyl-pyridine ureas as antagonists of the purinergic P2Y12 receptor.
    Bach P; Boström J; Brickmann K; van Giezen JJ; Hovland R; Petersson AU; Ray A; Zetterberg F
    Bioorg Med Chem Lett; 2011 May; 21(10):2877-81. PubMed ID: 21507636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BF061, a novel antiplatelet and antithrombotic agent targeting P2Y₁₂ receptor and phosphodiesterase.
    Hu L; Fan Z; Du H; Ni R; Zhang S; Yin K; Ye J; Zhang Y; Wei X; Zhang X; Gross PL; Kunapuli SP; Ding Z
    Thromb Haemost; 2011 Dec; 106(6):1203-14. PubMed ID: 21946947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-alkyl-1,3-oxazole derivatives of 6-amino-nicotinic acids as alkyl ester bioisosteres are antagonists of the P2Y12 receptor.
    Bach P; Boström J; Brickmann K; Burgess LE; Clarke D; Groneberg RD; Harvey DM; Laird ER; O'Sullivan M; Zetterberg F
    Future Med Chem; 2013 Nov; 5(17):2037-56. PubMed ID: 24215345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of 2-phenyl-pyrimidine-4-carboxamides towards potent, orally bioavailable and selective P2Y(12) antagonists for inhibition of platelet aggregation.
    Caroff E; Meyer E; Treiber A; Hilpert K; Riederer MA
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4323-31. PubMed ID: 25113932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New potent calcimimetics: II. Discovery of benzothiazole trisubstituted ureas.
    Deprez P; Temal T; Jary H; Auberval M; Lively S; Guédin D; Vevert JP
    Bioorg Med Chem Lett; 2013 Apr; 23(8):2455-9. PubMed ID: 23499504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel antiplatelet agent ticagrelor in the management of acute coronary syndrome.
    Ramaraj R; Movahed MR; Hashemzadeh M
    J Interv Cardiol; 2011 Jun; 24(3):199-207. PubMed ID: 21198849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The platelet P2 receptors in arterial thrombosis.
    Gachet C; Léon C; Hechler B
    Blood Cells Mol Dis; 2006; 36(2):223-7. PubMed ID: 16466948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.